These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion]. Słojewski M Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306 [TBL] [Abstract][Full Text] [Related]
27. Re: Matthew E. Nielsen, Shahrokh F. Shariat, Pierre I. Karakiewicz et al. Advanced age is associated with poorer bladder cancer-specific survival in patients treated with radical cystectomy. Eur urol 2007;51:699-708. Cai T; Bartoletti R Eur Urol; 2007 Aug; 52(2):611-2. PubMed ID: 17400362 [No Abstract] [Full Text] [Related]
29. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival. Bastian PJ; Hutterer GC; Shariat SF; Rogers CG; Palapattu GS; Lotan Y; Vazina A; Amiel GE; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP; Karakiewicz PI; BJU Int; 2008 Feb; 101(4):450-4. PubMed ID: 17850359 [TBL] [Abstract][Full Text] [Related]
30. Human epidermal growth factor receptor 2 expression status provides independent prognostic information in patients with urothelial carcinoma of the urinary bladder. Bolenz C; Shariat SF; Karakiewicz PI; Ashfaq R; Ho R; Sagalowsky AI; Lotan Y BJU Int; 2010 Oct; 106(8):1216-22. PubMed ID: 20089105 [TBL] [Abstract][Full Text] [Related]
31. Twelve-year follow up of a randomized prospective trial comparing bacillus Calmette-Guerin and epirubicin as adjuvant therapy in superficial bladder cancer. Cheng CW; Chan SF; Chan LW; Chan CK; Ng CF; Cheung HY; Chan SY; Wong WS; Lai FM; To KF; Li ML Int J Urol; 2005 May; 12(5):449-55. PubMed ID: 15948743 [TBL] [Abstract][Full Text] [Related]
32. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival. Dotan ZA; Kavanagh K; Yossepowitch O; Kaag M; Olgac S; Donat M; Herr HW J Urol; 2007 Dec; 178(6):2308-12; discussion 2313. PubMed ID: 17936804 [TBL] [Abstract][Full Text] [Related]
33. Relationship among cystectomy, microvessel density and prognosis in stage T1 transitional cell carcinoma of the bladder. Dinney CP; Babkowski RC; Antelo M; Perrotte P; Liebert M; Zhang HZ; Palmer J; Veltri RW; Katz RL; Grossman HB J Urol; 1998 Oct; 160(4):1285-90. PubMed ID: 9751337 [TBL] [Abstract][Full Text] [Related]
34. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder. May M; Nitzke T; Helke C; Vogler H; Hoschke B Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377 [TBL] [Abstract][Full Text] [Related]
35. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium. Shariat SF; Karakiewicz PI; Palapattu GS; Lotan Y; Rogers CG; Amiel GE; Vazina A; Gupta A; Bastian PJ; Sagalowsky AI; Schoenberg MP; Lerner SP J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118 [TBL] [Abstract][Full Text] [Related]
36. An immunohistochemical and prognostic evaluation of cathepsin D expression in 105 bladder carcinomas. Dickinson AJ; Fox SB; Newcomb PV; Persad RA; Sibley GN; Harris AL J Urol; 1995 Jul; 154(1):237-41. PubMed ID: 7776437 [TBL] [Abstract][Full Text] [Related]
37. Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder. Hara I; Miyake H; Hara S; Arakawa S; Kamidono S J Urol; 2001 May; 165(5):1769-72. PubMed ID: 11342973 [TBL] [Abstract][Full Text] [Related]